Daniel Ezekwudo
Overview
Explore the profile of Daniel Ezekwudo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanona P, Ezekwudo D, Anderson J
Front Oncol
. 2024 Dec;
14:1464362.
PMID: 39664200
Papillary craniopharyngiomas are rare tumors prevalent to the precision oncology world due to their high rate of BRAF V600E mutations. Symptoms include vision loss, neuroendocrine dysfunction, and cognitive dysfunction. Treatment...
2.
Idogun P, Hafez-Khayyata S, Ezekwudo D
Cureus
. 2024 Jul;
16(6):e61489.
PMID: 38952584
Guillain-Barré syndrome (GBS) resulting from the use of immune checkpoint inhibitors (ICIs) is relatively uncommon but has been reported. Herein, we discuss a case of a 67-year-old patient who received...
3.
Hanona P, Ezekwudo D, Anderson J, Jaiyesimi I
Cureus
. 2024 Mar;
16(1):e53234.
PMID: 38425591
A chondrosarcoma with pulmonary metastatic calcifications is a rarely reported phenomenon. This report discusses chondrosarcomas and their clinical features, diagnosis, and treatment, using as an example the case of a...
4.
Hanona P, Ezekwudo D, Fullmer J, Allen T, Jaiyesimi I
Thorac Cancer
. 2024 Feb;
15(10):847-851.
PMID: 38390699
SMARCA4-deficient undifferentiated thoracic tumors are a rare phenomenon. A 40-year-old male was newly diagnosed with SMARCA4-deficient undifferentiated non-small cell lung cancer. He had a history of heavy smoking and job-related...
5.
Chen B, Kanaan C, Jaiyesimi I, Ezekwudo D, Swor R
Prehosp Emerg Care
. 2020 Jan;
24(6):813-821.
PMID: 31961753
Although life-threatening emergencies for cancer patients are relatively rare, cancer patients often seek care in the emergency department. The use of emergency medical service (EMS) by these patients is not...
6.
Ezekwudo D, Lupak O, Vaddepally R, Gbadamosi B, Kuriakose P
Clin Case Rep
. 2018 Aug;
6(8):1504-1506.
PMID: 30147892
Certain histopathological findings have been described in acute myeloid leukemia (AML) patients during treatment that define the hematologic outcomes. Such entities as bone marrow necrosis and hemophagocytic lymphohistiocytosis have been...
7.
Gbadamosi B, Ezekwudo D, Bastola S, Jaiyesimi I
Clin Lymphoma Myeloma Leuk
. 2018 May;
18(7):e287-e294.
PMID: 29803615
Background: Acute myeloid leukemia (AML) is a heterogeneous malignancy with diverse genetic abnormalities, clinical presentations, and outcomes. Known predictive and prognostic factors in AML include age, performance status, comorbidities, cytogenetics,...
8.
Gbadamosi B, Ezekwudo D, Nayak B, Yu Z, Gjorgova-Gjeorgjievski S, Xie M, et al.
Case Reports Immunol
. 2018 May;
2018:4520294.
PMID: 29796327
Malignant melanoma is responsible for the majority of skin cancer deaths and is increasing in prevalence. Bone marrow (BM) involvement by melanoma is rare in the absence of widespread visceral...
9.
Tobi M, Thomas P, Ezekwudo D
World J Gastroenterol
. 2016 Jun;
22(24):5479-94.
PMID: 27350726
Much has been written about hepatic metastasis and animal models abound. In terms of the human experience, progress in treating this final common pathway, a terminal event of many human...
10.
Shashidharamurthy R, Zhang F, Amano A, Kamat A, Panchanathan R, Ezekwudo D, et al.
J Immunol
. 2009 Dec;
183(12):8216-24.
PMID: 20007585
CD32A, the major phagocytic FcgammaR in humans, exhibits a polymorphism in the ligand binding domain. Individuals homozygous for the R allelic form of CD32A (CD32A(R) allele) are more susceptible to...